Deviating central and local HER2 reports were already reported for various gastric cancer cohorts (Byeon et al. 2017; Huemer et al. 2020; Monges-Ranchin et al. 2016; Press et al. 2017). The gene discussed is ERBB2; the disease is gastric cancer.